Dissemin is shutting down on January 1st, 2025

Published in

American Association for the Advancement of Science, Science, 6561(373), p. 1349-1353, 2021

DOI: 10.1126/science.abk2718

Links

Tools

Export citation

Search in Google Scholar

The gRAMP CRISPR-Cas effector is an RNA endonuclease complexed with a caspase-like peptidase

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

CRISPR and Caspase meet Many prokaryotes use CRISPR RNA–bound proteins to sense viral RNA instead of DNA to set an immune response in motion that protects from virus infection. Although these ribonucleoproteins are typically composed of many protein subunits, van Beljouw et al . discovered that CRISPR-Cas type III-E systems are formed by a large, single-component effector protein capable of double RNA cleavage. Distinct from other systems, this effector forms a complex with a peptidase from the caspase family, raising the intriguing possibility that viral RNA activates a protease activity to prevent virus propagation by host suicide. —DJ